← Leaderboards
Jeremy James Martinson
University Of Pittsburgh At Pittsburgh
$18,580,412
Attributed
$38,722,051
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2017–25$10M$7.5M$5M$2.5M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,722,051 · 2
By mechanism
U01$38,722,051 · 2
Top collaborators
- Charles R Rinaldo18 shared
- Mackey R Friedman2 shared
- Lawrence A. Kingsley1 shared
- Sarah Krier1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Anuradha Ray$26,369,891
- John F McDyer$10,518,722
- Alison Morris$31,399,077
- Charles R Rinaldo$100,535,685
- Fernando Holguin$10,342,142
Others in their field
Other Emerging Leaders on “Participant”
- Chanza Baytop · Westat, Inc.$271,217,917
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Beth Baseler · Leidos Biomedical Research, Inc.$117,364,154
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$102,389,765
- Scott Topper · Broad Institute, Inc.$101,052,360
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
Research focus
ParticipantComorbidityHiv InfectionsCohort StudiesInsightWomanCardiovascular SystemIncidenceAgingSpecimenBehavioralChronicInnovationImmunologicsAids PreventionPsychosocialEpidemicNeurocognitiveCohortClinical ManagementBiologicalClinical Research SiteLungMalignant Neoplasms
Grant awards (18)
University of Pittsburgh MACS/WIHS CCS$3,961,545
U01 · FY2025 · HL
University of Pittsburgh MACS/WIHS CCS$4,049,466
U01 · FY2024 · HL
University of Pittsburgh MACS/WIHS CCS$4,084,069
U01 · FY2023 · HL
University of Pittsburgh MACS/WIHS CCS$4,064,074
U01 · FY2022 · HL
Association of Oral Microbiome, HIV, and Pulmonary Function$576,878
U01 · FY2022 · HL
University of Pittsburgh MACS/WIHS CCS$4,249,415
U01 · FY2021 · HL
COVID-19 vaccine serologic immune response in people with HIV$751,032
U01 · FY2021 · HL
Innovation Fund Application to the MACS/WIHS Combined Cohort Study (MWCCS): COVID-19 Vaccine Acceptance and Hesitancy (CVHB) Study in People with HIV$251,550
U01 · FY2021 · HL
University of Pittsburgh MACS/WIHS CCS$4,055,102
U01 · FY2020 · HL
COVID-19 and the MWCCS: Pathophysiology, Impact and Outcomes$359,561
U01 · FY2020 · HL
MWCCS ETOH supplement$157,146
U01 · FY2020 · HL
Study of Hearing and Balance in Middle Aged and Aging Men and Women in the MACS-WIHS Combined Cohort Study$53,185
U01 · FY2020 · HL
COVID-19 and the MWCCS: Psychosocial and Structural Impact on Physical and Mental Health, and HIV Prevention Behaviors$22,649
U01 · FY2020 · HL
University of Pittsburgh MACS/WIHS CCS$3,600,000
U01 · FY2019 · HL
University of Pittsburgh MACS/WIHS CCS- Supplement Funds from NHLBI$397,060
U01 · FY2019 · HL
University of Pittsburgh MACS/WIHS CCS- Supplement Funds from other ICs$53,453
U01 · FY2019 · HL
University of Pittsburgh Multicenter AIDS Cohort Study (MACS)$3,752,160
U01 · FY2018 · AI
University of Pittsburgh Multicenter AIDS Cohort Study (MACS)$4,283,706
U01 · FY2017 · AI